UnitedHealth (UNH) director Hooper reports 249-share dividend equivalent grant

Rhea-AI Filing Summary

UnitedHealth Group director reports additional stock via dividend equivalents. Director Michele J. Hooper reported acquiring 249 shares of UnitedHealth Group common stock on 12/16/2025 at a price of $0 per share. These shares represent dividend equivalents paid on vested deferred stock units and are immediately vested, carrying the same terms as the underlying deferred stock units. Following this transaction, she beneficially owns 41,126 shares of UnitedHealth Group common stock in direct ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOOPER MICHELE J

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/16/2025		A		249(1)	A	$0	41,126	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Michele J. Hooper	12/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UnitedHealth Group (UNH) disclose for Michele J. Hooper?

Director Michele J. Hooper reported acquiring 249 shares of UnitedHealth Group common stock on 12/16/2025. The shares were received as dividend equivalents on vested deferred stock units at a price of $0 per share.

How many UnitedHealth Group (UNH) shares does Michele J. Hooper own after this transaction?

After the reported transaction, Michele J. Hooper beneficially owns 41,126 shares of UnitedHealth Group common stock, held in direct ownership.

What is the nature of the 249 UnitedHealth Group (UNH) shares acquired by Michele J. Hooper?

The 249 shares represent dividend equivalents paid on vested deferred stock units. These dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

What type of SEC filing reports Michele J. Hooper’s UnitedHealth Group (UNH) transaction?

The transaction is reported on an SEC Form 4, which discloses changes in the beneficial ownership of equity securities by company insiders such as directors and officers.

Was the UnitedHealth Group (UNH) dividend equivalent transaction a purchase for cash?

No. The 249 shares were acquired at a reported price of $0 per share as dividend equivalents on vested deferred stock units, rather than through a cash purchase in the open market.

What is Michele J. Hooper’s relationship to UnitedHealth Group (UNH)?

Michele J. Hooper is reported as a Director of UnitedHealth Group. The Form 4 indicates the filing is made by one reporting person.